Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Neoplasms × Electrochemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vulvar Neoplasms 2 Melanoma 2 Liver Metastases 2 Breast Neoplasms 2 Ulcer 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Pathologic Processes 1 Pancreatic Neoplasms 1 Neoplastic Processes 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma, Cutaneous Malignant 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Gynecological Cancers 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Breast Cancer Female 1

Interventions

Sorafenib 38 Oxaliplatin 21 Bevacizumab 21 Radiosurgery 15 Fluorouracil 15 Gemcitabine 14 Nivolumab 11 Hepatectomy 11 Cisplatin 11 lenvatinib 10 Radiotherapy 10 Radiofrequency Ablation 9 Leucovorin 9 Doxorubicin 9 durvalumab 8 Liver Transplantation 8 Blood Specimen Collection 8 atezolizumab 7 Capecitabine 7 pembrolizumab 6 camrelizumab 6 Immunohistochemistry 6 Everolimus 6 Electroporation 6 Cyclophosphamide 6 Cryosurgery 6 tremelimumab 5 sintilimab 5 apatinib 5 Sunitinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed

25 enrolled 6 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡